⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20045620 | 0.75 | — | — | |
| SCHEMBL24817811 | 0.73 | — | — | |
| SCHEMBL22169299 | 0.73 | — | — | |
| SCHEMBL18312499 | 0.71 | — | — | |
| SCHEMBL25162448 | 0.71 | — | — | |
| SCHEMBL25465182 | 0.69 | — | — | |
| SCHEMBL23193169 | 0.69 | — | — | |
| SCHEMBL24576559 | 0.69 | — | — | |
| SCHEMBL22101198 | 0.69 | — | — | |
| SCHEMBL13069965 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3686196-A1 | POLYCYCLIC COMPOUND ACTING AS IDO INHIBITOR AND/OR IDO-HDAC DUAL INHIBITOR | Hangzhou Innogate Pharma Co., Ltd. (CN) | 2020-07-29 | — | — | EP | disclosed |